15 Nov 2023 Orionis Biosciences announces first patient dosed in Phase 1 clinical trial of ORB-011 in patients with advanced solid tumors Member news
14 Nov 2023 SwiftPharma and PlantForm target blockbuster cancer drug with new contract manufacturing agreement for plant-made biosimilars Member news
19 Oct 2023 Sequana Medical announces additional alfapump data supporting strong and durable clinical profile; PMA on track for year-end submission Member news
19 Oct 2023 Belgian researchers demonstrate that the gut microbiome can help predict the course of multiple sclerosis Member news
09 Oct 2023 SwiftPharma launches ODIN.AI: A groundbreaking AI-augmented antibody discovery platform Member news
21 Sep 2023 argenx announces VYVGART (efgartigimod alfa) authorized for sale by Health Canada for generalized myasthenia gravis Member news
08 Sep 2023 SwiftPharma and the Population Council Pursue Agreement to Manufacture Griffithsin Needed for the Development of a Fast-Dissolving Insert for Protection Against HIV Member news
01 Sep 2023 SwiftPharma and AntoXa Corporation sign exclusive collaboration agreement to support the development and commercialization of a plant-made antibody against ricin exposure Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
